| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -220 @ USD 119.18 | USD -26,220 | The ETF sold 220 shares of DVA on 2025-12-02. The shares were previously bought for an average price of USD 142.007. The DaVita HealthCare Partners Inc shares were sold for -16.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,022 The average price that the ETF previously sold DVA share for is USD 143.084 which is higher than the selling price of USD 119.18 on 2025-12-02. |
| HSIC - Henry Schein Inc | SELL | -638 @ USD 71.67 | USD -45,725 | The ETF sold 638 shares of HSIC on 2025-12-02. The shares were previously bought for an average price of USD 70.6832. The Henry Schein Inc shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 630 The average price that the ETF previously sold HSIC share for is USD 69.7144 so the ETF has sold 638 shares on 2025-12-02 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -330 @ USD 145.97 | USD -48,170 | The ETF sold 330 shares of MOH on 2025-12-02. The shares were previously bought for an average price of USD 238.415. The MOH shares were sold for -38.8% lower than average price of previous purchases. This resulted in an overall loss of USD 30,507 The average price that the ETF previously sold MOH share for is USD 289.461 which is higher than the selling price of USD 145.97 on 2025-12-02. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -330 @ USD 145.97 | USD -48,170 | The ETF sold 330 shares of MOH on 2025-12-02. The shares were previously bought for an average price of USD 238.415. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -38.8% lower than average price of previous purchases. This resulted in an overall loss of USD 30,507 The average price that the ETF previously sold MOH share for is USD 289.461 which is higher than the selling price of USD 145.97 on 2025-12-02. |
| MRNA - Moderna Inc | SELL | -2,112 @ USD 24.06 | USD -50,815 | The ETF sold 2112 shares of MRNA on 2025-12-02. The shares were previously bought for an average price of USD 30.1828. The Moderna Inc shares were sold for -20.3% lower than average price of previous purchases. This resulted in an overall loss of USD 12,931 The average price that the ETF previously sold MRNA share for is USD 37.6973 which is higher than the selling price of USD 24.06 on 2025-12-02. |
| CRL - Creightons Plc | SELL | -297 @ USD 174.76 | USD -51,904 | The ETF sold 297 shares of CRL on 2025-12-02. The shares were previously bought for an average price of USD 166.396. The Creightons Plc shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of USD 2,484 The average price that the ETF previously sold CRL share for is USD 174.743 so the ETF has sold 297 shares on 2025-12-02 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -3,157 @ USD 18.84 | USD -59,478 | The ETF sold 3157 shares of BAX on 2025-12-02. The shares were previously bought for an average price of USD 27.8745. The Baxter International Inc shares were sold for -32.4% lower than average price of previous purchases. This resulted in an overall loss of USD 28,522 The average price that the ETF previously sold BAX share for is USD 30.8795 which is higher than the selling price of USD 18.84 on 2025-12-02. |
| TECH - Bio-Techne Corp | SELL | -957 @ USD 62.95 | USD -60,243 | The ETF sold 957 shares of TECH on 2025-12-02. The shares were previously bought for an average price of USD 60.7264. The Bio-Techne Corp shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 2,128 The average price that the ETF previously sold TECH share for is USD 65.937 which is higher than the selling price of USD 62.95 on 2025-12-02. |
| ALGN - Align Technology Inc | SELL | -407 @ USD 150.93 | USD -61,429 | The ETF sold 407 shares of ALGN on 2025-12-02. The shares were previously bought for an average price of USD 167.206. The Align Technology Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,624 The average price that the ETF previously sold ALGN share for is USD 200.581 which is higher than the selling price of USD 150.93 on 2025-12-02. |
| RVTY - Revvity Inc. | SELL | -726 @ USD 102.73 | USD -74,582 | The ETF sold 726 shares of RVTY on 2025-12-02. The shares were previously bought for an average price of USD 103.026. The Revvity Inc. shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 215 The average price that the ETF previously sold RVTY share for is USD 107.72 which is higher than the selling price of USD 102.73 on 2025-12-02. |
| VTRS - Viatris Inc | SELL | -7,095 @ USD 10.71 | USD -75,987 | The ETF sold 7095 shares of VTRS on 2025-12-02. The shares were previously bought for an average price of USD 10.2851. The Viatris Inc shares were sold for 4.1% higher than average price of previous purchases. This sale made a profit of USD 3,015 The average price that the ETF previously sold VTRS share for is USD 11.1559 which is higher than the selling price of USD 10.71 on 2025-12-02. |
| SOLV - Solventum Corp. | SELL | -902 @ USD 85.59 | USD -77,202 | The ETF sold 902 shares of SOLV on 2025-12-02. The shares were previously bought for an average price of USD 73.4461. The Solventum Corp. shares were sold for 16.5% higher than average price of previous purchases. This sale made a profit of USD 10,954 The average price that the ETF previously sold SOLV share for is USD 71.282 so the ETF has sold 902 shares on 2025-12-02 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -341 @ USD 238.68 | USD -81,390 | The ETF sold 341 shares of UHS on 2025-12-02. The shares were previously bought for an average price of USD 194.577. The Universal Health Services Inc shares were sold for 22.7% higher than average price of previous purchases. This sale made a profit of USD 15,039 The average price that the ETF previously sold UHS share for is USD 192.266 so the ETF has sold 341 shares on 2025-12-02 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -1,232 @ USD 75.84 | USD -93,435 | The ETF sold 1232 shares of COO on 2025-12-02. The shares were previously bought for an average price of USD 80.6821. The The Cooper Companies, Inc. Common Stock shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,965 The average price that the ETF previously sold COO share for is USD 89.1563 which is higher than the selling price of USD 75.84 on 2025-12-02. |
| HOLX - Hologic Inc | SELL | -1,364 @ USD 74.82 | USD -102,054 | The ETF sold 1364 shares of HOLX on 2025-12-02. The shares were previously bought for an average price of USD 68.1202. The Hologic Inc shares were sold for 9.8% higher than average price of previous purchases. This sale made a profit of USD 9,139 The average price that the ETF previously sold HOLX share for is USD 70.81 so the ETF has sold 1364 shares on 2025-12-02 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -1,012 @ USD 101.44 | USD -102,657 | The ETF sold 1012 shares of INCY on 2025-12-02. The shares were previously bought for an average price of USD 79.3654. The Incyte Corporation shares were sold for 27.8% higher than average price of previous purchases. This sale made a profit of USD 22,339 The average price that the ETF previously sold INCY share for is USD 73.9209 so the ETF has sold 1012 shares on 2025-12-02 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -2,871 @ USD 38.81 | USD -111,424 | The ETF sold 2871 shares of CNC on 2025-12-02. The shares were previously bought for an average price of USD 47.0607. The Concurrent Technologies Plc shares were sold for -17.5% lower than average price of previous purchases. This resulted in an overall loss of USD 23,688 The average price that the ETF previously sold CNC share for is USD 52.9383 which is higher than the selling price of USD 38.81 on 2025-12-02. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -1,210 @ USD 94.14 | USD -113,909 | The ETF sold 1210 shares of ZBH on 2025-12-02. The shares were previously bought for an average price of USD 102.136. The Zimmer Biomet Holdings Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,675 The average price that the ETF previously sold ZBH share for is USD 103.94 which is higher than the selling price of USD 94.14 on 2025-12-02. |
| WST - West Pharmaceutical Services Inc | SELL | -429 @ USD 273.03 | USD -117,130 | The ETF sold 429 shares of WST on 2025-12-02. The shares were previously bought for an average price of USD 256.527. The West Pharmaceutical Services Inc shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 7,080 The average price that the ETF previously sold WST share for is USD 285.673 which is higher than the selling price of USD 273.03 on 2025-12-02. |
| DGX - Quest Diagnostics Incorporated | SELL | -671 @ USD 182.55 | USD -122,491 | The ETF sold 671 shares of DGX on 2025-12-02. The shares were previously bought for an average price of USD 174.687. The Quest Diagnostics Incorporated shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 5,276 The average price that the ETF previously sold DGX share for is USD 164.852 so the ETF has sold 671 shares on 2025-12-02 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -429 @ USD 309 | USD -132,561 | The ETF sold 429 shares of PODD on 2025-12-02. The shares were previously bought for an average price of USD 296.201. The Insulet Corporation shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 5,491 The average price that the ETF previously sold PODD share for is USD 275.795 so the ETF has sold 429 shares on 2025-12-02 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -506 @ USD 265.93 | USD -134,561 | The ETF sold 506 shares of LH on 2025-12-02. The shares were previously bought for an average price of USD 256.732. The Laboratory Corporation of America Holdings shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 4,654 The average price that the ETF previously sold LH share for is USD 242.481 so the ETF has sold 506 shares on 2025-12-02 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -363 @ USD 398.62 | USD -144,699 | The ETF sold 363 shares of WAT on 2025-12-02. The shares were previously bought for an average price of USD 349.87. The Waters Corporation shares were sold for 13.9% higher than average price of previous purchases. This sale made a profit of USD 17,696 The average price that the ETF previously sold WAT share for is USD 363.425 so the ETF has sold 363 shares on 2025-12-02 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -363 @ USD 398.62 | USD -144,699 | The ETF sold 363 shares of WAT on 2025-12-02. The shares were previously bought for an average price of USD 349.87. The MULETFWATIMETFP shares were sold for 13.9% higher than average price of previous purchases. This sale made a profit of USD 17,696 The average price that the ETF previously sold WAT share for is USD 363.425 so the ETF has sold 363 shares on 2025-12-02 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -594 @ USD 259.3 | USD -154,024 | The ETF sold 594 shares of STE on 2025-12-02. The shares were previously bought for an average price of USD 234.943. The STERIS plc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 14,468 The average price that the ETF previously sold STE share for is USD 222.439 so the ETF has sold 594 shares on 2025-12-02 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -2,398 @ USD 64.45 | USD -154,551 | The ETF sold 2398 shares of DXCM on 2025-12-02. The shares were previously bought for an average price of USD 74.7852. The DexCom Inc shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 24,784 The average price that the ETF previously sold DXCM share for is USD 76.6321 which is higher than the selling price of USD 64.45 on 2025-12-02. |
| BIIB - Biogen Inc | SELL | -891 @ USD 180.18 | USD -160,540 | The ETF sold 891 shares of BIIB on 2025-12-02. The shares were previously bought for an average price of USD 144.969. The Biogen Inc shares were sold for 24.3% higher than average price of previous purchases. This sale made a profit of USD 31,373 The average price that the ETF previously sold BIIB share for is USD 151.753 so the ETF has sold 891 shares on 2025-12-02 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -121 @ USD 1447.16 | USD -175,106 | The ETF sold 121 shares of MTD on 2025-12-02. The shares were previously bought for an average price of USD 1289.23. The Mettler-Toledo International Inc shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 19,110 The average price that the ETF previously sold MTD share for is USD 1242.13 so the ETF has sold 121 shares on 2025-12-02 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -121 @ USD 1447.16 | USD -175,106 | The ETF sold 121 shares of MTD on 2025-12-02. The shares were previously bought for an average price of USD 1289.23. The AMUNDI EUR GOV 710 shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 19,110 The average price that the ETF previously sold MTD share for is USD 1242.13 so the ETF has sold 121 shares on 2025-12-02 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -726 @ USD 241.96 | USD -175,663 | The ETF sold 726 shares of HUM on 2025-12-02. The shares were previously bought for an average price of USD 264.684. The Hummingbird Resources PLC shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 16,498 The average price that the ETF previously sold HUM share for is USD 268.279 which is higher than the selling price of USD 241.96 on 2025-12-02. |
| HUM - Humana Inc | SELL | -726 @ USD 241.96 | USD -175,663 | The ETF sold 726 shares of HUM on 2025-12-02. The shares were previously bought for an average price of USD 264.684. The Humana Inc shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 16,498 The average price that the ETF previously sold HUM share for is USD 268.279 which is higher than the selling price of USD 241.96 on 2025-12-02. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -2,772 @ USD 80.22 | USD -222,370 | The ETF sold 2772 shares of GEHC on 2025-12-02. The shares were previously bought for an average price of USD 78.8701. The GE HealthCare Technologies Inc. shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 3,742 The average price that the ETF previously sold GEHC share for is USD 79.0883 so the ETF has sold 2772 shares on 2025-12-02 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -891 @ USD 250.85 | USD -223,507 | The ETF sold 891 shares of RMD on 2025-12-02. The shares were previously bought for an average price of USD 251.512. The ResMed Inc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 590 The average price that the ETF previously sold RMD share for is USD 244.25 so the ETF has sold 891 shares on 2025-12-02 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -1,034 @ USD 225.63 | USD -233,301 | The ETF sold 1034 shares of IQV on 2025-12-02. The shares were previously bought for an average price of USD 193.065. The IQVIA Holdings Inc shares were sold for 16.9% higher than average price of previous purchases. This sale made a profit of USD 33,672 The average price that the ETF previously sold IQV share for is USD 189.803 so the ETF has sold 1034 shares on 2025-12-02 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -1,727 @ USD 148.81 | USD -256,995 | The ETF sold 1727 shares of A on 2025-12-02. The shares were previously bought for an average price of USD 130.265. The Agilent Technologies Inc shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 32,027 The average price that the ETF previously sold A share for is USD 130.849 so the ETF has sold 1727 shares on 2025-12-02 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -1,441 @ USD 205.13 | USD -295,592 | The ETF sold 1441 shares of CAH on 2025-12-02. The shares were previously bought for an average price of USD 149.356. The Cardinal Health Inc shares were sold for 37.3% higher than average price of previous purchases. This sale made a profit of USD 80,370 The average price that the ETF previously sold CAH share for is USD 136.365 so the ETF has sold 1441 shares on 2025-12-02 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -3,575 @ USD 84.71 | USD -302,838 | The ETF sold 3575 shares of EW on 2025-12-02. The shares were previously bought for an average price of USD 75.1746. The Edwards Lifesciences Corp shares were sold for 12.7% higher than average price of previous purchases. This sale made a profit of USD 34,089 The average price that the ETF previously sold EW share for is USD 72.4112 so the ETF has sold 3575 shares on 2025-12-02 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -1,738 @ USD 190.47 | USD -331,037 | The ETF sold 1738 shares of BDX on 2025-12-02. The shares were previously bought for an average price of USD 205.467. The Becton Dickinson and Company shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 26,065 The average price that the ETF previously sold BDX share for is USD 210.012 which is higher than the selling price of USD 190.47 on 2025-12-02. |
| ZTS - Zoetis Inc | SELL | -2,695 @ USD 124.44 | USD -335,366 | The ETF sold 2695 shares of ZTS on 2025-12-02. The shares were previously bought for an average price of USD 154.463. The Zoetis Inc shares were sold for -19.4% lower than average price of previous purchases. This resulted in an overall loss of USD 80,912 The average price that the ETF previously sold ZTS share for is USD 165.861 which is higher than the selling price of USD 124.44 on 2025-12-02. |
| IDXX - IDEXX Laboratories Inc | SELL | -484 @ USD 732.73 | USD -354,641 | The ETF sold 484 shares of IDXX on 2025-12-02. The shares were previously bought for an average price of USD 553.34. The IDEXX Laboratories Inc shares were sold for 32.4% higher than average price of previous purchases. This sale made a profit of USD 86,825 The average price that the ETF previously sold IDXX share for is USD 471.808 so the ETF has sold 484 shares on 2025-12-02 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -1,166 @ USD 350.67 | USD -408,881 | The ETF sold 1166 shares of COR on 2025-12-02. The shares were previously bought for an average price of USD 298.064. The Cencora Inc. shares were sold for 17.6% higher than average price of previous purchases. This sale made a profit of USD 61,339 The average price that the ETF previously sold COR share for is USD 265.426 so the ETF has sold 1166 shares on 2025-12-02 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -1,617 @ USD 274.1 | USD -443,220 | The ETF sold 1617 shares of CI on 2025-12-02. The shares were previously bought for an average price of USD 301.075. The Cigna Corp shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 43,619 The average price that the ETF previously sold CI share for is USD 309.774 which is higher than the selling price of USD 274.1 on 2025-12-02. |
| ELV - Elevance Health Inc | SELL | -1,364 @ USD 330.92 | USD -451,375 | The ETF sold 1364 shares of ELV on 2025-12-02. The shares were previously bought for an average price of USD 366.251. The Elevance Health Inc shares were sold for -9.6% lower than average price of previous purchases. This resulted in an overall loss of USD 48,191 The average price that the ETF previously sold ELV share for is USD 387.676 which is higher than the selling price of USD 330.92 on 2025-12-02. |
| ELV - Elevance Health Inc | SELL | -1,364 @ USD 330.92 | USD -451,375 | The ETF sold 1364 shares of ELV on 2025-12-02. The shares were previously bought for an average price of USD 366.251. The Elevance Health Inc shares were sold for -9.6% lower than average price of previous purchases. This resulted in an overall loss of USD 48,191 The average price that the ETF previously sold ELV share for is USD 387.676 which is higher than the selling price of USD 330.92 on 2025-12-02. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -616 @ USD 742 | USD -457,072 | The ETF sold 616 shares of REGN on 2025-12-02. The shares were previously bought for an average price of USD 652.68. The Regeneron Pharmaceuticals Inc shares were sold for 13.7% higher than average price of previous purchases. This sale made a profit of USD 55,021 The average price that the ETF previously sold REGN share for is USD 688.417 so the ETF has sold 616 shares on 2025-12-02 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -990 @ USD 500.31 | USD -495,307 | The ETF sold 990 shares of HCA on 2025-12-02. The shares were previously bought for an average price of USD 384.016. The HCA Holdings Inc shares were sold for 30.3% higher than average price of previous purchases. This sale made a profit of USD 115,131 The average price that the ETF previously sold HCA share for is USD 357.369 so the ETF has sold 990 shares on 2025-12-02 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -12,320 @ USD 48.25 | USD -594,440 | The ETF sold 12320 shares of BMY on 2025-12-02. The shares were previously bought for an average price of USD 51.528. The Bloomsbury Publishing Plc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 40,385 The average price that the ETF previously sold BMY share for is USD 53.6653 which is higher than the selling price of USD 48.25 on 2025-12-02. |
| CVS - CVS Health Corp | SELL | -7,678 @ USD 77.62 | USD -595,966 | The ETF sold 7678 shares of CVS on 2025-12-02. The shares were previously bought for an average price of USD 68.9629. The CVS Health Corp shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 66,469 The average price that the ETF previously sold CVS share for is USD 59.265 so the ETF has sold 7678 shares on 2025-12-02 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -748 @ USD 829.7 | USD -620,616 | The ETF sold 748 shares of MCK on 2025-12-02. The shares were previously bought for an average price of USD 698.361. The McKesson Corporation shares were sold for 18.8% higher than average price of previous purchases. This sale made a profit of USD 98,242 The average price that the ETF previously sold MCK share for is USD 644.075 so the ETF has sold 748 shares on 2025-12-02 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -1,551 @ USD 433.15 | USD -671,816 | The ETF sold 1551 shares of VRTX on 2025-12-02. The shares were previously bought for an average price of USD 441.292. The Vertex Pharmaceuticals Inc shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 12,628 The average price that the ETF previously sold VRTX share for is USD 458.561 which is higher than the selling price of USD 433.15 on 2025-12-02. |
| SYK - Stryker Corporation | SELL | -2,079 @ USD 366.68 | USD -762,328 | The ETF sold 2079 shares of SYK on 2025-12-02. The shares were previously bought for an average price of USD 375.96. The Stryker Corporation shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of USD 19,293 The average price that the ETF previously sold SYK share for is USD 377.084 which is higher than the selling price of USD 366.68 on 2025-12-02. |
| MDT - Medtronic PLC | SELL | -7,755 @ USD 102.03 | USD -791,243 | The ETF sold 7755 shares of MDT on 2025-12-02. The shares were previously bought for an average price of USD 91.3943. The Medtronic PLC shares were sold for 11.6% higher than average price of previous purchases. This sale made a profit of USD 82,480 The average price that the ETF previously sold MDT share for is USD 86.654 so the ETF has sold 7755 shares on 2025-12-02 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -34,441 @ USD 25.15 | USD -866,191 | The ETF sold 34441 shares of PFE on 2025-12-02. The shares were previously bought for an average price of USD 25.2749. The Pfizer Inc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,302 The average price that the ETF previously sold PFE share for is USD 25.5404 which is higher than the selling price of USD 25.15 on 2025-12-02. |
| DHR - Danaher Corporation | SELL | -3,850 @ USD 226.59 | USD -872,372 | The ETF sold 3850 shares of DHR on 2025-12-02. The shares were previously bought for an average price of USD 213.011. The Danaher Corporation shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 52,279 The average price that the ETF previously sold DHR share for is USD 223.193 so the ETF has sold 3850 shares on 2025-12-02 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -3,850 @ USD 226.59 | USD -872,372 | The ETF sold 3850 shares of DHR on 2025-12-02. The shares were previously bought for an average price of USD 213.011. The Danaher Corporation shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 52,279 The average price that the ETF previously sold DHR share for is USD 223.193 so the ETF has sold 3850 shares on 2025-12-02 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -8,965 @ USD 99.02 | USD -887,714 | The ETF sold 8965 shares of BSX on 2025-12-02. The shares were previously bought for an average price of USD 99.9911. The Boston Scientific Corporation shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,706 The average price that the ETF previously sold BSX share for is USD 94.1081 so the ETF has sold 8965 shares on 2025-12-02 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -8,965 @ USD 99.02 | USD -887,714 | The ETF sold 8965 shares of BSX on 2025-12-02. The shares were previously bought for an average price of USD 99.9911. The MULSTRXSSXIMETFP shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,706 The average price that the ETF previously sold BSX share for is USD 94.1081 so the ETF has sold 8965 shares on 2025-12-02 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -7,513 @ USD 123.91 | USD -930,936 | The ETF sold 7513 shares of GILD on 2025-12-02. The shares were previously bought for an average price of USD 110.819. The Guild Esports Plc shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 98,353 The average price that the ETF previously sold GILD share for is USD 99.9074 so the ETF has sold 7513 shares on 2025-12-02 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -3,256 @ USD 338.36 | USD -1,101,700 | The ETF sold 3256 shares of AMGN on 2025-12-02. The shares were previously bought for an average price of USD 302.038. The Amgen Inc shares were sold for 12.0% higher than average price of previous purchases. This sale made a profit of USD 118,264 The average price that the ETF previously sold AMGN share for is USD 290.337 so the ETF has sold 3256 shares on 2025-12-02 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -2,167 @ USD 567.72 | USD -1,230,249 | The ETF sold 2167 shares of ISRG on 2025-12-02. The shares were previously bought for an average price of USD 517.491. The Intuitive Surgical Inc shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of USD 108,846 The average price that the ETF previously sold ISRG share for is USD 529.184 so the ETF has sold 2167 shares on 2025-12-02 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -2,277 @ USD 580.37 | USD -1,321,502 | The ETF sold 2277 shares of TMO on 2025-12-02. The shares were previously bought for an average price of USD 515.655. The Time Out Group plc shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 147,356 The average price that the ETF previously sold TMO share for is USD 501.011 so the ETF has sold 2277 shares on 2025-12-02 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -10,527 @ USD 126.32 | USD -1,329,771 | The ETF sold 10527 shares of ABT on 2025-12-02. The shares were previously bought for an average price of USD 128.763. The Abbott Laboratories shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 25,717 The average price that the ETF previously sold ABT share for is USD 121.94 so the ETF has sold 10527 shares on 2025-12-02 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -15,103 @ USD 101.03 | USD -1,525,856 | The ETF sold 15103 shares of MRK on 2025-12-02. The shares were previously bought for an average price of USD 89.0149. The Marks Electrical Group PLC shares were sold for 13.5% higher than average price of previous purchases. This sale made a profit of USD 181,464 The average price that the ETF previously sold MRK share for is USD 93.9067 so the ETF has sold 15103 shares on 2025-12-02 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -15,103 @ USD 101.03 | USD -1,525,856 | The ETF sold 15103 shares of MRK on 2025-12-02. The shares were previously bought for an average price of USD 89.0149. The Merck & Company Inc shares were sold for 13.5% higher than average price of previous purchases. This sale made a profit of USD 181,464 The average price that the ETF previously sold MRK share for is USD 93.9067 so the ETF has sold 15103 shares on 2025-12-02 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -5,467 @ USD 324.54 | USD -1,774,260 | The ETF sold 5467 shares of UNH on 2025-12-02. The shares were previously bought for an average price of USD 415.74. The UnitedHealth Group Incorporated shares were sold for -21.9% lower than average price of previous purchases. This resulted in an overall loss of USD 498,590 The average price that the ETF previously sold UNH share for is USD 482.41 which is higher than the selling price of USD 324.54 on 2025-12-02. |
| ABBV - AbbVie Inc | SELL | -10,670 @ USD 224.37 | USD -2,394,028 | The ETF sold 10670 shares of ABBV on 2025-12-02. The shares were previously bought for an average price of USD 204.561. The AbbVie Inc shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of USD 211,362 The average price that the ETF previously sold ABBV share for is USD 189.61 so the ETF has sold 10670 shares on 2025-12-02 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -14,553 @ USD 205.42 | USD -2,989,477 | The ETF sold 14553 shares of JNJ on 2025-12-02. The shares were previously bought for an average price of USD 170.545. The Johnson & Johnson shares were sold for 20.4% higher than average price of previous purchases. This sale made a profit of USD 507,536 The average price that the ETF previously sold JNJ share for is USD 156.623 so the ETF has sold 14553 shares on 2025-12-02 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -4,796 @ USD 1046.12 | USD -5,017,192 | The ETF sold 4796 shares of LLY on 2025-12-02. The shares were previously bought for an average price of USD 824.921. The Eli Lilly and Company shares were sold for 26.8% higher than average price of previous purchases. This sale made a profit of USD 1,060,870 The average price that the ETF previously sold LLY share for is USD 800.693 so the ETF has sold 4796 shares on 2025-12-02 at a higher price than the previous selling average. |